nach oben

Erschienen in:

21.08.2017 | Epidemiology

Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel

verfasst von: Jamal Zidan, Alicia Y. Zhou, Jeroen van den Akker, Yael Laitman, Hagit Schayek, Julia Schnaider, Eitan Friedman

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The contribution of genetic factors to cancer in non-Jewish populations in Israel is understudied. Yet the early, mostly premenopausal age at breast cancer diagnosis is suggestive of an inherited predisposition.

Methods

High-risk cancer cases of non-Jewish origin who were counseled at the Oncogenetics unit, Sheba Medical Center and the oncology institute at the Ziv medical center from January 1, 2000 to December 31 2016 were eligible. DNA extracted from leukocytes was subjected to massive parallel, next-generation sequencing using the Color Genomics platform. Data were analyzed for pathogenic and likely pathogenic mutations using existing pipelines.

Results

Overall, 68 cases, each representing a unique high-risk breast/ovarian family, were genotyped: 32 Druze, 26 Muslim Arabs, and 10 Christian Arabs. Fifty-nine had breast cancer (mean age at diagnosis 42.7 ± 7.6 years), and 9 had ovarian cancer (51.6 ± 9.7 years). Overall three pathogenic mutations one each in BRCA1, PALB2, and BRIP1 genes were detected mostly in Druze families. In addition, 29 variants of unknown significance were also detected, and in 36 cases no sequence variants were noted in any of the genotyped genes.

Conclusion

The contribution of the known cancer susceptibility genes to the burden of inherited breast/ovarian cancer predisposition in non-Jews in Israel is modest. Other genes or molecular mechanisms account for the familial breast/ovarian cancer clustering in this population.

Nur mit Berechtigung zugänglich

Kleibl Z, Kristensen VN (2016) Women at high risk of breast cancer: molecular characteristics, clinical presentation and management. Breast 28:136–144. doi:10.1016/j.breast.2016.05.006 CrossRefPubMed

Cobain EF, Milliron KJ, Merajver SD (2016) Updates on breast cancer genetics: clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer. Semin Oncol 43(5):528–535. doi:10.1053/j.seminoncol.2016.10.001 CrossRefPubMed

Zhang B, Beeghly-Fadiel A, Long J, Zheng W (2011) Genetic variants associated with breast cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol 12(5):477–488CrossRefPubMedPubMedCentral

Economopoulou P, Dimitriadis G, Psyrri A (2015) Beyond BRCA: new hereditary breast cancer susceptibility genes. Cancer Treat Rev 41(1):1–8. doi:10.1016/j.ctrv.2014.10.008 CrossRefPubMed

Tarabeia J, Baron-Epel O, Barchana M, Liphshitz I, Ifrah A, Fishler Y, Green MS (2007) A comparison of trends in incidence and mortality rates of breast cancer, incidence to mortality ratio and stage at diagnosis between Arab and Jewish women in Israel, 1979–2002. Eur J Cancer Prev 16:36–42CrossRefPubMed

Nissan A, Spira RM, Hamburger T, Badrriyah M, Prus D, Cohen T, Hubert A, Freund HR, Peretz T (2004) Clinical profile of breast cancer in Arab and Jewish women in the Jerusalem area. Am J Surg 188:62–67CrossRefPubMed

Peto J (2002) Breast cancer susceptibility—a new look at an old model. Cancer Cell 1(5):411–412CrossRefPubMed

Morak M, Heidenreich B, Keller G, Hampel H, Laner A, de la Chapelle A, Holinski-Feder E (2014) Biallelic MUTYH mutations can mimic Lynch syndrome. Eur J Hum Genet 22(11):1334–1337. doi:10.1038/ejhg.2014 CrossRefPubMedPubMedCentral

Durno CA, Sherman PM, Aronson M, Malkin D, Hawkins C, Bakry D, Bouffet E, Gallinger S, Pollett A, Campbell B, Tabori U, International BMMRD Consortium (2015) Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome. Eur J Cancer 51(8):977–983CrossRefPubMed

10.

Walsh T, Casadei S, Lee MK, Pennil CC, Nord AS, Thornton AM, Roeb W, Agnew KJ, Stray SM, Wickramanayake A, Norquist B, Pennington KP, Garcia RL, King MC, Swisher EM (2011) Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci USA 108:18032–18037CrossRefPubMedPubMedCentral

11.

LaDuca H, Stuenkel AJ, Dolinsky JS, Keiles S, Tandy S, Pesaran T, Chen E, Gau CL, Palmaer E, Shoaepour K, Shah D, Speare V, Gandomi S, Chao E (2014) Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2000 patients. Genet Med 16:830–837CrossRefPubMedPubMedCentral

12.

Selkirk CG, Vogel KJ, Newlin AC, Weissman SM, Weiss SM, Wang CH, Hulick PJ (2014) Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice. Fam Cancer 13:527–536CrossRefPubMed

13.

Easton DF, Pharoah PDP, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M, Goldgar DE, Evans DG, Chenevix-Trench G, Rahman N, Robson M, Domchek SM, Foulkes WD (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372:2243–2257CrossRefPubMedPubMedCentral

14.

Gatalica Z, Ghazalpour A, Lilleberg SL, Swensen J, Lynch HT (2016) The molecular basis of human cancer in “Hereditary Cancer” In: Coleman WB, Tsongalis GJ (eds) Springer, New York, pp. 335–353

15.

Crawford B, Adams SB, Sittler T, van den Akker J, Chan S, Leitner O, Ryan L, Gil E, van ‘t Veer L (2017) Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients. Breast Cancer Res Treat 163(2):383–390. doi:10.1007/s10549-017-4181-0 CrossRefPubMedPubMedCentral

16.

Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK, Wang Q, Dennis J, Ahmad J, Thompson ER, Damiola F, Pertesi M, Voegele C, Mebirouk N, Robinot N, Durand G, Forey N, Luben RN, Ahmed S, Aittomäki K, Anton-Culver H, Arndt V, Australian Ovarian Cancer Study Group, Baynes C, Beckman MW, Benitez J, Van Den Berg D, Blot WJ, Bogdanova NV, Bojesen SE, Brenner H, Chang-Claude J, Chia KS, Choi JY, Conroy DM, Cox A, Cross SS, Czene K, Darabi H, Devilee P, Eriksson M, Fasching PA, Figueroa J, Flyger H, Fostira F, García-Closas M, Giles GG, Glendon G, González-Neira A, Guénel P, Haiman CA, Hall P, Hart SN, Hartman M, Hooning MJ, Hsiung CN, Ito H, Jakubowska A, James PA, John EM, Johnson N, Jones M, Kabisch M, Kang D, kConFab Investigators, Kosma VM, Kristensen V, Lambrechts D, Li N, Lifepool Investigators, Lindblom A, Long J, Lophatananon A, Lubinski J, Mannermaa A, Manoukian S, Margolin S, Matsuo K, Meindl A, Mitchell G, Muir K, NBCS Investigators, Nevelsteen I, van den Ouweland A, Peterlongo P, Phuah SY, Pylkäs K, Rowley SM, Sangrajrang S, Schmutzler RK, Shen CY, Shu XO, Southey MC, Surowy H, Swerdlow A, Teo SH, Tollenaar RA, Tomlinson I, Torres D, Truong T, Vachon C, Verhoef S, Wong-Brown M, Zheng W, Zheng Y, Nevanlinna H, Scott RJ, Andrulis IL, Wu AH, Hopper JL, Couch FJ, Winqvist R, Burwinkel B, Sawyer EJ, Schmidt MK, Rudolph A, Dörk T, Brauch H, Hamann U, Neuhausen SL, Milne RL, Fletcher O, Pharoah PD, Campbell IG, Dunning AM, Le Calvez-Kelm F, Goldgar DE, Tavtigian SV, Chenevix-Trench G (2016) No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. J Med Genet 53(5):298–309. doi:10.1136/jmedgenet-2015-103529 CrossRefPubMedPubMedCentral

17.

Laitman Y, Borsthein RT, Stoppa-Lyonnet D, Dagan E, Castera L, Goislard M, Gershoni-Baruch R, Goldberg H, Kaufman B, Ben-Baruch N, Zidan J, Maray T, Soussan-Gutman L, Friedman E (2011) Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel. Breast Cancer Res Treat 127(2):489–495. doi:10.1007/s10549-010-1217-0 CrossRefPubMed

18.

Kadouri L, Bercovich D, Elimelech A, Lerer I, Sagi M, Glusman G, Shochat C, Korem S, Hamburger T, Nissan A, Abu-Halaf N, Badrriyah M, Abeliovich D, Peretz T (2007) A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer. BMC Cancer 7:14–20CrossRefPubMedPubMedCentral

19.

El-Harith EH, Abdel-Hadi MS, Steinmann D, Dork T (2002) BRCA1 and BRCA2 mutations in breast cancer patients from Saudi Arabia. Saudi Med J 23(6):700–704

20.

Zick A, Kadouri L, Cohen S, Frohlinger M, Hamburger T, Zvi N, Plaser M, Avital E, Breuier S, Elian F, Salah A, Goldberg Y, Peretz T (2017) Recurrent TP53 missense mutation in cancer patients of Arab descent. Fam Cancer 16(2):295–301. doi:10.1007/s10689-016-9951-z CrossRefPubMed

21.

Amemiya Y, Bacopulos S, Al-Shawarby M, Al-Tamimi D, Naser W, Ahmed A, Khalifa M, Slodkowska E, Seth AA (2015) Comparative analysis of breast and ovarian cancer-related gene mutations in Canadian and Saudi Arabian patients with breast cancer. Anticancer Res 35(5):2601–2610PubMed

22.

Jalkh N, Chouery E, Haidar Z, Khater C, Atallah D, Ali H, Marafie MJ, Al-Mulla MR, Al-Mulla F, Megarbane A (2017) Next-generation sequencing in familial breast cancer patients from Lebanon. BMC Med Genom 10(1):8. doi:10.1186/s12920-017-0244-7 CrossRef

23.

Merdad A, Gari MA, Hussein S, Al-Khayat S, Tashkandi H, Al-Maghrabi J, Al-Thubaiti F, Hussein IR, Koumosani T, Shaer N, Chaudhary AG, Abuzenadah AM, Al-Qahtani MH, Dallol A (2015) Characterization of familial breast cancer in Saudi Arabia. BMC Genom 16(Suppl 1):S3. doi:10.1186/1471-2164-16-S1-S3 CrossRef

24.

Denic S, Frampton C, Nicholls MG (2007) Risk of cancer in an inbred population. Cancer Detect Prev 31(4):263–269CrossRefPubMed

25.

Bener A, El Ayoubi HR, Chouchane L, Ali AI, Al-Kubaisi A, Al-Sulaiti H, Teebi AS (2009) Impact of consanguinity on cancer in a highly endogamous population. Asian Pac J Cancer Prev 10(1):35–40PubMed

Titel: Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel
verfasst von: Jamal Zidan
Alicia Y. Zhou
Jeroen van den Akker
Yael Laitman
Hagit Schayek
Julia Schnaider
Eitan Friedman
Publikationsdatum: 21.08.2017
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 3/2017
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-017-4474-3

Springer Medizin

Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel